← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2005Last known activity
Apr 28, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06909799CollaboratorN/AApr 28, 2025
- NCT06114628CollaboratorPhase 2Dec 8, 2023
- NCT02349841CollaboratorPhase 2Sep 1, 2014
- NCT00311051Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2005
- NCT00311051Lead sponsorPhase 2/Phase 3Apr 1, 2005
Details
- Last known activity
- Apr 28, 2025